Artemether and Cariprazine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Artemether
No brand names on recordCariprazine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. Artemether (part of a malaria treatment) can speed up an enzyme in your body called CYP3A4. Your antipsychotic cariprazine (Vraylar) is broken down by that same enzyme. So when you take them together, your body may clear cariprazine a little faster, which could make it less effective at controlling your symptoms.
The good news is this is based on theory, not strong real-world reports, and malaria treatment is usually short. Please don't stop or change either medicine on your own. Let your doctor or pharmacist know you're on both so they can keep an eye on how you're doing.
Mechanism: Artemether/lumefantrine may induce CYP3A4, potentially increasing metabolism of cariprazine, a CYP3A4 substrate.
- Direction: Reduced cariprazine exposure (AUC/Cmax), risk of diminished antipsychotic efficacy.
- Evidence: Theoretical; magnitude not quantified.
- Onset: Unspecified; artemether courses are typically short, limiting sustained induction.
- Consideration: Cariprazine and its active metabolites have long half-lives, which may buffer transient induction effects.
Management: Monitor for loss of symptom control during and shortly after antimalarial therapy. Dose may be individualized by the care team; no fixed adjustment is defined.
What happens
Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate
Interaction Deep Dive
Use care if artemether/lumefantrine is given together with substrates of CYP3A4, since this combination can lower the exposure of those CYP3A4 substrates and thereby diminish their effectiveness1.
Why it happens (mechanism)
Induction of CYP3A4-substrate metabolism by artemether/lumefantrine
How to manage this interaction
What your care team may do:
- Keep taking both medicines exactly as prescribed unless told otherwise.
- Watch for any return or worsening of your mood or psychiatric symptoms during the malaria treatment and for a while after.
- Your team may monitor you more closely, and your cariprazine dose may be adjusted and individualized if needed.
What you should do: Tell your pharmacist or prescriber that you take cariprazine before starting the antimalarial. Report any changes in how you feel. Since malaria treatment is usually short, this is very manageable with a little extra attention.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Artemether and Cariprazine together?
Artemether may slightly lower how well cariprazine works by clearing it faster, but the evidence is only theoretical and the malaria course is short. Keep taking both as prescribed and tell your care team so they can watch for any drop in symptom control. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Artemether and Cariprazine interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Artemether and Cariprazine interaction managed?
What your care team may do: Keep taking both medicines exactly as prescribed unless told otherwise. Watch for any return or worsening of your mood or psychiatric symptoms during the malaria treatment and for a while after. Your team may monitor you more closely, and your cariprazine dose may be adjusted and individualized if needed. What you should do: Tell your pharmacist or prescriber that you t… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Artemether or Cariprazine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (1)
- Product Information: COARTEM® oral tablets, artemether lumefantrine oral tablets. Novartis Pharmaceuticals Corporation (per DailyMed), East Hanover, NJ, 2025. DailyMed
Keep reading about Artemether
Keep reading about Cariprazine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist